Accounts of Chemical Research, 1991, 24 9: 264-270
So that might leave you to ask, Whats the harm in trying even if its a placebo effect? Because thats what trying peptides like BPC-157 comes down to: being your own little experiment, minus the safeguards or informed consent of a clinical trial
The aim of this study was to assess additive CV, metabolic, and renal effects of combination therapy with SGLT2i and newer generation GLP-1RA compared with SGLT2i alone among people with T2D with ASCVD, T2D, and T2D with CKD, respectively
The mechanism of action includes stimulating insulin secretion in a glucose-dependent manner, suppressing glucagon release , slowing gastric emptying , and acting centrally on the hypothalamus and brainstem to increase satiety and reduce appetite